326 related articles for article (PubMed ID: 28477470)
1. Targeted delivery and pH-responsive release of doxorubicin to cancer cells using calcium carbonate/hyaluronate/glutamate mesoporous hollow spheres.
Guo Y; Li H; Shi W; Zhang J; Feng J; Yang X; Wang K; Zhang H; Yang L
J Colloid Interface Sci; 2017 Sep; 502():59-66. PubMed ID: 28477470
[TBL] [Abstract][Full Text] [Related]
2. Stimuli-sensitive hollow spheres from chitosan-graft-β-cyclodextrin for controlled drug release.
Yu N; Li G; Gao Y; Liu X; Ma S
Int J Biol Macromol; 2016 Dec; 93(Pt A):971-977. PubMed ID: 27663551
[TBL] [Abstract][Full Text] [Related]
3. Hollow microspheres based on - Folic acid modified - Hydroxypropyl Cellulose and synthetic multi-responsive bio-copolymer for targeted cancer therapy: controlled release of daunorubicin, in vitro and in vivo studies.
Metaxa AF; Efthimiadou EK; Boukos N; Fragogeorgi EA; Loudos G; Kordas G
J Colloid Interface Sci; 2014 Dec; 435():171-81. PubMed ID: 25261841
[TBL] [Abstract][Full Text] [Related]
4. Hollow Mesoporous Silica@Metal-Organic Framework and Applications for pH-Responsive Drug Delivery.
Jia X; Yang Z; Wang Y; Chen Y; Yuan H; Chen H; Xu X; Gao X; Liang Z; Sun Y; Li JR; Zheng H; Cao R
ChemMedChem; 2018 Mar; 13(5):400-405. PubMed ID: 29337422
[TBL] [Abstract][Full Text] [Related]
5. Rattle-type Fe(3)O(4)@SiO(2) hollow mesoporous spheres as carriers for drug delivery.
Zhu Y; Ikoma T; Hanagata N; Kaskel S
Small; 2010 Feb; 6(3):471-8. PubMed ID: 19943250
[TBL] [Abstract][Full Text] [Related]
6. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells.
Zhao Q; Liu J; Zhu W; Sun C; Di D; Zhang Y; Wang P; Wang Z; Wang S
Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronic acid-modified multiwalled carbon nanotubes for targeted delivery of doxorubicin into cancer cells.
Cao X; Tao L; Wen S; Hou W; Shi X
Carbohydr Res; 2015 Mar; 405():70-7. PubMed ID: 25500334
[TBL] [Abstract][Full Text] [Related]
8. Hydrothermal fabrication of porous hollow hydroxyapatite microspheres for a drug delivery system.
Lai W; Chen C; Ren X; Lee IS; Jiang G; Kong X
Mater Sci Eng C Mater Biol Appl; 2016 May; 62():166-72. PubMed ID: 26952411
[TBL] [Abstract][Full Text] [Related]
9. A preloaded amorphous calcium carbonate/doxorubicin@silica nanoreactor for pH-responsive delivery of an anticancer drug.
Zhao Y; Luo Z; Li M; Qu Q; Ma X; Yu SH; Zhao Y
Angew Chem Int Ed Engl; 2015 Jan; 54(3):919-22. PubMed ID: 25422068
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
[TBL] [Abstract][Full Text] [Related]
11. pH-responsive targeted and controlled doxorubicin delivery using hyaluronic acid nanocarriers.
Gurav DD; Kulkarni AS; Khan A; Shinde VS
Colloids Surf B Biointerfaces; 2016 Jul; 143():352-358. PubMed ID: 27022876
[TBL] [Abstract][Full Text] [Related]
12. pH and Glutathione Dual-Responsive Dynamic Cross-Linked Supramolecular Network on Mesoporous Silica Nanoparticles for Controlled Anticancer Drug Release.
Li QL; Xu SH; Zhou H; Wang X; Dong B; Gao H; Tang J; Yang YW
ACS Appl Mater Interfaces; 2015 Dec; 7(51):28656-64. PubMed ID: 26633741
[TBL] [Abstract][Full Text] [Related]
13. Dual stimuli-responsive polymeric hollow nanogels designed as carriers for intracellular triggered drug release.
Chiang WH; Ho VT; Huang WC; Huang YF; Chern CS; Chiu HC
Langmuir; 2012 Oct; 28(42):15056-64. PubMed ID: 23036055
[TBL] [Abstract][Full Text] [Related]
14. Aerosol-Assisted Synthesis of Tailor-Made Hollow Mesoporous Silica Microspheres for Controlled Release of Antibacterial and Anticancer Agents.
Poostforooshan J; Belbekhouche S; Shaban M; Alphonse V; Habert D; Bousserrhine N; Courty J; Weber AP
ACS Appl Mater Interfaces; 2020 Feb; 12(6):6885-6898. PubMed ID: 31967774
[TBL] [Abstract][Full Text] [Related]
15. In situ mineralization of anticancer drug into calcium carbonate monodisperse nanospheres and their pH-responsive release property.
Yang T; Wan Z; Liu Z; Li H; Wang H; Lu N; Chen Z; Mei X; Ren X
Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():384-92. PubMed ID: 27040233
[TBL] [Abstract][Full Text] [Related]
16. A pH-Responsive Hydrogel Based on a Tumor-Targeting Mesoporous Silica Nanocomposite for Sustained Cancer Labeling and Therapy.
Chen X; Liu Z
Macromol Rapid Commun; 2016 Sep; 37(18):1533-9. PubMed ID: 27448182
[TBL] [Abstract][Full Text] [Related]
17. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
18. Hollow silica nanospheres coated with insoluble calcium salts for pH-responsive sustained release of anticancer drugs.
Guo Y; Fang Q; Li H; Shi W; Zhang J; Feng J; Jia W; Yang L
Chem Commun (Camb); 2016 Aug; 52(70):10652-5. PubMed ID: 27501741
[TBL] [Abstract][Full Text] [Related]
19. A targeted drug delivery system based on folic acid-functionalized upconversion luminescent nanoparticles.
Liang X; Fan J; Zhao Y; Cheng M; Wang X; Jin R; Sun T
J Biomater Appl; 2017 Apr; 31(9):1247-1256. PubMed ID: 28350205
[TBL] [Abstract][Full Text] [Related]
20. Preparation of pH-responsive mesoporous hydroxyapatite nanoparticles for intracellular controlled release of an anticancer drug.
Li D; Huang X; Wu Y; Li J; Cheng W; He J; Tian H; Huang Y
Biomater Sci; 2016 Feb; 4(2):272-80. PubMed ID: 26484364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
